Personal CFO Solutions’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $557K | Hold |
|
|||||
|
2025
Q1 | $466K | Buy |
|
|||||
|
2024
Q4 | $463K | Sell |
|
|||||
|
2024
Q3 | $469K | Hold |
|
|||||
|
2024
Q2 | $381K | Sell |
|
|||||
|
2024
Q1 | $339K | Buy |
|
|||||
|
2023
Q4 | $397K | Sell |
|
|||||
|
2023
Q3 | $473K | Hold |
|
|||||
|
2023
Q2 | $470K | Sell |
|
|||||
|
2023
Q1 | $565K | Buy |
|
|||||
|
2022
Q4 | $774K | Hold |
|
|||||
|
2022
Q3 | $849K | Buy |
|
|||||
|
2022
Q2 | $710K | Sell |
|
|||||
|
2022
Q1 | $1.77M | Hold |
|
|||||
|
2021
Q4 | $1.51M | Hold |
|
|||||
|
2021
Q3 | $1.57M | Sell |
|
|||||
|
2021
Q2 | $1.77M | Sell |
|
|||||
|
2021
Q1 | $1.24M | Buy |
|
|||||
|
2020
Q4 | $784K | Buy |
|
|||||
|
2020
Q3 | $0 | Buy |
|
|||||
|
2020
Q2 | $394K | Sell |
|
|||||
|
2020
Q1 | $174K | Buy |
|
|||||
|
2019
Q4 | $110K | Buy |
|